INCYHealth careBiotechnology
$122.85
Close on Nov 4, 2026
$25.0B
Incyte develops medicines for cancer and skin diseases; its biggest product is Jakafi, for certain blood cancers.
As reported in the company's annual report (10-K).
Useful context, but not the main focus.
Drag across the chart to compare two days.Touch the chart with two fingers to compare two days.
What it is · Why it matters · How to read it in context.
Annual figures, fiscal years 2021-2025.
Financial figures come from company filings with the U.S. Securities and Exchange Commission (SEC). Latest filing used: October 29, 2026. Stock prices are end-of-day closing prices.